← Volver a Khronus
A $100 Billion Drug Discount Program Is Finally Facing New Scrutiny
ForbesNegocios

A $100 Billion Drug Discount Program Is Finally Facing New Scrutiny

Fecha de publicación: 19 de octubre de 2026, 12:00

The federal government is taking a new approach to overseeing one of the country's fastest-growing healthcare programs.

Fuente oficial: Forbes
Leer artículo en origen